CNC Quote, Financials, Valuation and Earnings

Elevance Health, Inc. has a net margin of -13.35% compared to Centene Corp.'s net margin of 2.34%. Centene Corp.'s return on equity of -20.3% beat Elevance Health, Inc.'s return on equity of 12.81%.

Centene Corp. has a consensus price target of $40.41, signalling upside risk potential of 1.16%. On the other hand Elevance Health, Inc. has an analysts' consensus of $389.21 which suggests that it could grow by 13.4%. Given that Elevance Health, Inc. has higher upside potential than Centene Corp., analysts believe Elevance Health, Inc. is more attractive than Centene Corp..

Centene Corp. has a beta of 0.476, which suggesting that the stock is 52.425% less volatile than S&P 500. In comparison Elevance Health, Inc. has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.789%.

Centene Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health, Inc. offers a yield of 1.99% to investors and pays a quarterly dividend of $1.71 per share. Centene Corp. pays -- of its earnings as a dividend. Elevance Health, Inc. pays out 25.39% of its earnings as a dividend. Elevance Health, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Centene Corp. quarterly revenues are $49.7B, which are smaller than Elevance Health, Inc. quarterly revenues of $50.7B. Centene Corp.'s net income of -$6.6B is lower than Elevance Health, Inc.'s net income of $1.2B. Notably, Centene Corp.'s price-to-earnings ratio is 8.66x while Elevance Health, Inc.'s PE ratio is 14.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centene Corp. is 0.11x versus 0.40x for Elevance Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare, Inc. has a net margin of -13.35% compared to Centene Corp.'s net margin of 0.69%. Centene Corp.'s return on equity of -20.3% beat Molina Healthcare, Inc.'s return on equity of 19.74%.

Centene Corp. has a consensus price target of $40.41, signalling upside risk potential of 1.16%. On the other hand Molina Healthcare, Inc. has an analysts' consensus of $176.63 which suggests that it could grow by 7.69%. Given that Molina Healthcare, Inc. has higher upside potential than Centene Corp., analysts believe Molina Healthcare, Inc. is more attractive than Centene Corp..

Centene Corp. has a beta of 0.476, which suggesting that the stock is 52.425% less volatile than S&P 500. In comparison Molina Healthcare, Inc. has a beta of 0.516, suggesting its less volatile than the S&P 500 by 48.37%.

Centene Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Molina Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Centene Corp. pays -- of its earnings as a dividend. Molina Healthcare, Inc. pays out -- of its earnings as a dividend.

Centene Corp. quarterly revenues are $49.7B, which are larger than Molina Healthcare, Inc. quarterly revenues of $11.5B. Centene Corp.'s net income of -$6.6B is lower than Molina Healthcare, Inc.'s net income of $79M. Notably, Centene Corp.'s price-to-earnings ratio is 8.66x while Molina Healthcare, Inc.'s PE ratio is 10.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centene Corp. is 0.11x versus 0.20x for Molina Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health, Inc. has a net margin of -13.35% compared to Centene Corp.'s net margin of -4.6%. Centene Corp.'s return on equity of -20.3% beat Oscar Health, Inc.'s return on equity of -21.36%.

Centene Corp. has a consensus price target of $40.41, signalling upside risk potential of 1.16%. On the other hand Oscar Health, Inc. has an analysts' consensus of $14.67 which suggests that it could fall by -1.17%. Given that Centene Corp. has higher upside potential than Oscar Health, Inc., analysts believe Centene Corp. is more attractive than Oscar Health, Inc..

Centene Corp. has a beta of 0.476, which suggesting that the stock is 52.425% less volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Centene Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Centene Corp. pays -- of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend.

Centene Corp. quarterly revenues are $49.7B, which are larger than Oscar Health, Inc. quarterly revenues of $3B. Centene Corp.'s net income of -$6.6B is lower than Oscar Health, Inc.'s net income of -$137.5M. Notably, Centene Corp.'s price-to-earnings ratio is 8.66x while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centene Corp. is 0.11x versus 0.35x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group, Inc. has a net margin of -13.35% compared to Centene Corp.'s net margin of 2.25%. Centene Corp.'s return on equity of -20.3% beat UnitedHealth Group, Inc.'s return on equity of 17.57%.

Centene Corp. has a consensus price target of $40.41, signalling upside risk potential of 1.16%. On the other hand UnitedHealth Group, Inc. has an analysts' consensus of $392.24 which suggests that it could grow by 20.76%. Given that UnitedHealth Group, Inc. has higher upside potential than Centene Corp., analysts believe UnitedHealth Group, Inc. is more attractive than Centene Corp..

Centene Corp. has a beta of 0.476, which suggesting that the stock is 52.425% less volatile than S&P 500. In comparison UnitedHealth Group, Inc. has a beta of 0.428, suggesting its less volatile than the S&P 500 by 57.182%.

Centene Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group, Inc. offers a yield of 2.69% to investors and pays a quarterly dividend of $2.21 per share. Centene Corp. pays -- of its earnings as a dividend. UnitedHealth Group, Inc. pays out 52.75% of its earnings as a dividend. UnitedHealth Group, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Centene Corp. quarterly revenues are $49.7B, which are smaller than UnitedHealth Group, Inc. quarterly revenues of $113.2B. Centene Corp.'s net income of -$6.6B is lower than UnitedHealth Group, Inc.'s net income of $2.5B. Notably, Centene Corp.'s price-to-earnings ratio is 8.66x while UnitedHealth Group, Inc.'s PE ratio is 16.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Centene Corp. is 0.11x versus 0.68x for UnitedHealth Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.